Long-term bone remodelling around 'legendary' cementless femoral stems
- PMID: 29657845
- PMCID: PMC5890130
- DOI: 10.1302/2058-5241.3.170024
Long-term bone remodelling around 'legendary' cementless femoral stems
Abstract
Bone remodelling around a stem is an unavoidable long-term physiological process highly related to implant design. For some predisposed patients, it can lead to periprosthetic bone loss secondary to severe stress-shielding, which is thought to be detrimental by contributing to late loosening, late periprosthetic fracture, and thus rendering revision surgery more complicated.However, these concerns remain theoretical, since late loosening has yet to be documented among bone ingrowth cementless stems demonstrating periprosthetic bone loss associated with stress-shielding.Because none of the stems replicate the physiological load pattern on the proximal femur, each stem design is associated with a specific load pattern leading to specific adaptive periprosthetic bone remodelling. In their daily practice, orthopaedic surgeons need to differentiate physiological long-term bone remodelling patterns from pathological conditions such as loosening, sepsis or osteolysis.To aid in that process, we decided to clarify the behaviour of the five most used femoral stems. In order to provide translational knowledge, we decided to gather the designers' and experts' knowledge and experience related to the design rationale and the long-term bone remodelling of the following femoral stems we deemed 'legendary' and still commonly used: Corail (Depuy); Taperloc (Biomet); AML (Depuy); Alloclassic (Zimmer); and CLS-Spotorno (Zimmer). Cite this article: EFORT Open Rev 2018;3:45-57. DOI: 10.1302/2058-5241.3.170024.
Keywords: bone remodelling; legendary stems.
Conflict of interest statement
ICMJE Conflict of interest statement: C. Rivière declares payment for lectures for Medacta, activity outside the submitted work. G. Grappiolo declares personal fees from Zimmer Biomet, outside the submitted work. C. Engh Jr. declares grants and other funds from DePuy Synthes Joint Reconstruction, a Division of DePuy Orthopaedics, Inc.; grants from Smith & Nephew, outside the submitted work. J.-P. Vidalain declares personal fees and other funds from Depuy, during the conduct of the study; in addition, patent FR 02 06122 with royalties paid to Depuy. A. F. Chen declares other funds from SLACK publishing, non-financial support from Joint Purification Systems, personal fees from ACI, personal fees from DJO, personal fees from Stryker, outside the submitted work. N. Boehler declares consultancy fees from Zimmer-Biomet, outside the submitted work. A.-P. Vendittoli declares consultancy fees from Medacta, Microport and Stryker; grants/grants pending from Medacta, Microport, Stryker and Zimmer; payment for lectures from Medacta, Stryker and Ethicon; royalties from Microport, outside the submitted work.
Figures
References
-
- McKee GK, Watson-Farrar J. Replacement of arthritic hips by the McKee-Farrar prosthesis. J Bone Joint Surg Br 1966;48:245-9. - PubMed
-
- Kawamoto K, Hasegawa Y, Iwase T, et al. Failed cementless total hip arthroplasty for osteoarthrosis due to hip dysplasia. A minimum five-year follow-up study. Bull Hosp Jt Dis 1998;57:130-5. - PubMed
-
- Albrektsson T, Brånemark PI, Hansson HA, Lindström J. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man. Acta Orthop Scand 1981;52:155-70. - PubMed
-
- Engh CA, McGovern TF, Bobyn JD, Harris WH. A quantitative evaluation of periprosthetic bone-remodeling after cementless total hip arthroplasty. J Bone Joint Surg Am 1992;74:1009-20. - PubMed
-
- Khanuja HS, Vakil JJ, Goddard MS, Mont MA. Cementless femoral fixation in total hip arthroplasty. J Bone Joint Surg Am 2011;93:500-9. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
